Cell Fusion in Malignancy: A Cause or Consequence? A Provocateur or Cure?
cell fusion
malignant transformation
progression
tumor immunity
tumor resistance
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
14 06 2019
14 06 2019
Historique:
received:
19
05
2019
revised:
06
06
2019
accepted:
08
06
2019
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
19
6
2019
Statut:
epublish
Résumé
Cell fusion has been observed in malignancy, and cancer cells have been found especially apt to fuse with other cells. Investigation of human and experimental malignancies suggests spontaneous fusion of normal cells can induce manifold genetic changes and manifestations of malignant transformation. Fusion of transformed cells with other cells can promote the progression of cancer to more malignant forms. However, observations in various fields suggest cell fusion also potentially contributes to natural defenses against cancer. Thus, cell fusion potentially corrects genetic and/or phenotypic changes underlying malignant transformation. Cell fusion also might help nonmalignant cells in tumors thwart tumor growth. Perhaps most importantly, cell fusion may generate genetic changes that lead to the expression of neoantigens, provide the mass of neoantigen expression needed to elicit immunity, and promote the function of antigen-presenting cells in a way that favors protective immunity as a defense against malignancy. To the extent that cell fusion promotes cellular, tissue, and/or systemic resistance to malignancy, the propensity of tumor cells to fuse with other cells might constitute a natural defense against malignancy.
Identifiants
pubmed: 31207918
pii: cells8060587
doi: 10.3390/cells8060587
pmc: PMC6628134
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Nature. 1976 Mar 4;260(5546):17-20
pubmed: 1264187
J Immunol. 2002 May 15;168(10):5233-9
pubmed: 11994480
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12396-400
pubmed: 21746894
Hum Immunol. 2019 Jun;80(6):363-377
pubmed: 30980861
Annu Rev Biochem. 1993;62:623-51
pubmed: 8394683
Ciba Found Symp. 1989;142:199-208; discussion 208-13
pubmed: 2743832
Adv Exp Med Biol. 2011;713:33-64
pubmed: 21432013
Stem Cells. 2013 Nov;31(11):2304-12
pubmed: 23897781
Science. 1970 Sep 4;169(3949):1006-11
pubmed: 4194203
PLoS Comput Biol. 2018 Jun 7;14(6):e1006233
pubmed: 29879111
Int J Mol Sci. 2016 Jul 13;17(7):
pubmed: 27420051
Am J Pathol. 2015 Jul;185(7):2049-60
pubmed: 26066710
Ann N Y Acad Sci. 2005 Dec;1055:35-47
pubmed: 16387716
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Prog Exp Tumor Res. 1970;13:1-27
pubmed: 4921480
Nature. 1974 Aug 23;250(5468):649-51
pubmed: 4859359
Hospital (Lond 1886). 1909 Jul 3;46(1195):349-350
pubmed: 29815590
J Immunol. 2004 May 1;172(9):5143-8
pubmed: 15100249
Curr Mol Med. 2013 Jun;13(5):735-50
pubmed: 23642055
Int J Mol Sci. 2018 May 21;19(5):
pubmed: 29883428
Nature. 2013 Sep 19;501(7467):346-54
pubmed: 24048067
Cell Commun Signal. 2018 Oct 13;16(1):67
pubmed: 30316300
J Med Res. 1912 Feb;25(3):503-514.1
pubmed: 19972041
J Exp Med. 2014 Jul 28;211(8):1503-23
pubmed: 25071162
J Immunol. 2000 Aug 1;165(3):1599-604
pubmed: 10903769
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
PLoS One. 2013 Jun 26;8(6):e66731
pubmed: 23840523
Nature. 2001 May 17;411(6835):390-5
pubmed: 11357148
Nature. 2001 Apr 26;410(6832):1107-11
pubmed: 11323675
Nat Med. 1997 May;3(5):558-61
pubmed: 9142127
Science. 2013 Nov 8;342(6159):699-700
pubmed: 24202164
Proc R Soc Med. 1910;3(Ther Pharmacol Sect):69-81
pubmed: 19974852
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8403-8
pubmed: 10900004
Nat Rev Cancer. 2008 May;8(5):377-86
pubmed: 18385683
Mol Cell Biol. 1983 Apr;3(4):523-38
pubmed: 6687920
Mol Cell Oncol. 2016 Nov 28;4(1):e1263715
pubmed: 28197538
Adv Immunol. 2016;130:25-74
pubmed: 26922999
Crit Rev Oncog. 2013;18(1-2):97-113
pubmed: 23237554
PLoS One. 2007 Sep 12;2(9):e876
pubmed: 17849005
JAMA. 2015 Nov 3;314(17):1850-60
pubmed: 26447779
Curr Opin Immunol. 2014 Apr;27:16-25
pubmed: 24531241
Br Med J. 1954 Dec 11;2(4901):1374-80
pubmed: 13209123
Oncotarget. 2017 May 18;8(31):51370-51386
pubmed: 28881654
Immunotherapy. 2017 Jun;9(8):659-667
pubmed: 28653569
PLoS One. 2015 Aug 12;10(8):e0134320
pubmed: 26267609
FASEB J. 2004 Mar;18(3):548-50
pubmed: 14715691
Br J Cancer. 1975 Oct;32(4):411-26
pubmed: 1212409
Nat Rev Mol Cell Biol. 2005 Jul;6(7):567-75
pubmed: 15957005
Neoplasia. 2013 Mar;15(3):249-62
pubmed: 23479504
Cell Rep. 2015 Jun 16;11(10):1549-63
pubmed: 26051943
Development. 2017 Dec 15;144(24):4481-4495
pubmed: 29254991
Int J Mol Sci. 2016 May 26;17(6):
pubmed: 27240347
Cancer Res. 2011 Feb 15;71(4):1497-505
pubmed: 21303980
Nat Rev Cancer. 2012 Mar 01;12(4):307-13
pubmed: 22378190
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Int J Mol Sci. 2016 Apr 28;17(5):
pubmed: 27136533
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10567-70
pubmed: 12149477
FASEB J. 2015 Sep;29(9):4036-45
pubmed: 26085132
BMC Cancer. 2017 Aug 2;17(1):515
pubmed: 28768501
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
JAMA. 2015 Nov 3;314(17):1806-7
pubmed: 26447685
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673):
pubmed: 26056359
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6447-E6456
pubmed: 27698134
Elife. 2016 Sep 19;5:
pubmed: 27642012
Nat Rev Cancer. 2007 Dec;7(12):968-76
pubmed: 18034186
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
Science. 1987 Dec 11;238(4833):1539-45
pubmed: 3317834
Cell Commun Signal. 2016 Sep 08;14(1):20
pubmed: 27608835
Nature. 1969 Jul 26;223(5204):363-8
pubmed: 5387828
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Methods Mol Biol. 2015;1313:21-40
pubmed: 25947654
PLoS One. 2017 Feb 1;12(2):e0168581
pubmed: 28146572
Trends Cancer. 2016 Oct;2(10):552-560
pubmed: 28439564
Cytokine Growth Factor Rev. 2002 Apr;13(2):95-109
pubmed: 11900986
Oncotarget. 2017 Dec 27;9(5):6156-6173
pubmed: 29464062
Curr Opin Organ Transplant. 2010 Aug;15(4):481-5
pubmed: 20613524
Nat Rev Cancer. 2018 Jul;18(7):433-441
pubmed: 29622806
Stem Cells. 2018 Jul;36(7):951-968
pubmed: 29603861
Yale J Biol Med. 1982 May-Aug;55(3-4):329-33
pubmed: 6758376
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271591
Bioessays. 2005 Aug;27(8):833-8
pubmed: 16015588
Biochim Biophys Acta. 2015 Aug;1856(1):1-12
pubmed: 25956199
Curr Opin Cell Biol. 2006 Dec;18(6):658-67
pubmed: 17046232
Melanoma Res. 2000 Dec;10(6):507-14
pubmed: 11198471
Int J Epidemiol. 2016 Jun;45(3):649-53
pubmed: 26659656
Cell Rep. 2018 Mar 6;22(10):2742-2755
pubmed: 29514101
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9385-90
pubmed: 19458257
Curr Biol. 2007 Mar 6;17(5):431-7
pubmed: 17320392
Front Oncol. 2018 Oct 09;8:431
pubmed: 30356678
Crit Rev Oncog. 2013;18(1-2):1-18
pubmed: 23237550
Nature. 1975 May 15;255(5505):197-200
pubmed: 1143315